Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 104 Lymphoma, Large B-Cell, Diffuse 81 Leukemia, Myeloid, Acute 75 Multiple Myeloma 71 Breast Neoplasms 70 Lymphoma, Non-Hodgkin 62 Lymphoma 62 Leukemia, Lymphocytic, Chronic, B-Cell 53 Burkitt Lymphoma 53 Recurrence 51 Myelodysplastic Syndromes 50 Lymphoma, Follicular 49 Lymphoma, B-Cell 48 Leukemia 43 Triple Negative Breast Neoplasms 40 Lymphoma, Mantle-Cell 38 Neoplasms 37 Melanoma 34 Hodgkin Disease 34 Lymphoma, B-Cell, Marginal Zone 32 Hematologic Neoplasms 31 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29 Neuroblastoma 28 Ovarian Neoplasms 26 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Neoplasm Metastasis 22 Pancreatic Neoplasms 21 Leukemia, Biphenotypic, Acute 21 Sarcoma 18 Myeloproliferative Disorders 17

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Childhood Solid Tumor × Cyclophosphamide × 1 year × Clear all

NCT03585465 2026-05-29

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Terminated

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡